106 related articles for article (PubMed ID: 15094046)
21. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
[TBL] [Abstract][Full Text] [Related]
22. Using Biotinylated SUMO-Traps to Analyze SUMOylated Proteins.
Lang V; Da Silva-Ferrada E; Barrio R; Sutherland JD; Rodriguez MS
Methods Mol Biol; 2016; 1475():109-21. PubMed ID: 27631801
[TBL] [Abstract][Full Text] [Related]
23. SP-RING for SUMO: new functions bloom for a ubiquitin-like protein.
Hochstrasser M
Cell; 2001 Oct; 107(1):5-8. PubMed ID: 11595179
[TBL] [Abstract][Full Text] [Related]
24. Redox-mediated modification of PLZF by SUMO-1 and ubiquitin.
Kang SI; Choi HW; Kim IY
Biochem Biophys Res Commun; 2008 May; 369(4):1209-14. PubMed ID: 18348865
[TBL] [Abstract][Full Text] [Related]
25. Identification of SUMO targets through in vitro expression cloning.
Gocke CB; Yu H
Methods Mol Biol; 2009; 497():51-61. PubMed ID: 19107410
[TBL] [Abstract][Full Text] [Related]
26. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.
Lois LM; Lima CD
EMBO J; 2005 Feb; 24(3):439-51. PubMed ID: 15660128
[TBL] [Abstract][Full Text] [Related]
27. Ribosomal protein S3 is stabilized by sumoylation.
Jang CY; Shin HS; Kim HD; Kim JW; Choi SY; Kim J
Biochem Biophys Res Commun; 2011 Oct; 414(3):523-7. PubMed ID: 21968017
[TBL] [Abstract][Full Text] [Related]
28. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
[TBL] [Abstract][Full Text] [Related]
29. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association.
Mahajan R; Gerace L; Melchior F
J Cell Biol; 1998 Jan; 140(2):259-70. PubMed ID: 9442102
[TBL] [Abstract][Full Text] [Related]
31. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
Saitoh H; Hinchey J
J Biol Chem; 2000 Mar; 275(9):6252-8. PubMed ID: 10692421
[TBL] [Abstract][Full Text] [Related]
32. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
Kang ES; Park CW; Chung JH
Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
[TBL] [Abstract][Full Text] [Related]
33. A Mutant Sumo Facilitates Quick Plasmid Construction for Expressing Proteins with Native N-termini After Tag Removal.
Zhang Y; Fan Y
Mol Biotechnol; 2017 May; 59(4-5):159-167. PubMed ID: 28349302
[TBL] [Abstract][Full Text] [Related]
34. Production of sumoylated proteins using a baculovirus expression system.
Langereis MA; Rosas-Acosta G; Mulder K; Wilson VG
J Virol Methods; 2007 Feb; 139(2):189-94. PubMed ID: 17208312
[TBL] [Abstract][Full Text] [Related]
35. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
[TBL] [Abstract][Full Text] [Related]
36. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
Bossis G; Melchior F
Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
[TBL] [Abstract][Full Text] [Related]
37. Human SUMO fusion systems enhance protein expression and solubility.
Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
[TBL] [Abstract][Full Text] [Related]
38. Expression, purification, and evaluation of in vivo anti-fibrotic activity for soluble truncated TGF-β receptor II as a cleavable His-SUMO fusion protein.
Wang X; Li Y; Li X; Yan L; Guan H; Han R; Han Y; Gui J; Xu X; Dong Y; Liu H
World J Microbiol Biotechnol; 2018 Nov; 34(12):181. PubMed ID: 30474742
[TBL] [Abstract][Full Text] [Related]
39. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Tian S; Poukka H; Palvimo JJ; Jänne OA
Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
[TBL] [Abstract][Full Text] [Related]
40. SUMO wrestling with specificity.
VanDemark AP; Hill CP
Structure; 2002 Mar; 10(3):281-2. PubMed ID: 12005425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
